Content Reviewed By
Reviewed by a board-certified physician (Medical) · Reviewed by a licensed attorney specializing in mass tort litigation (Legal)
How to File a Depo-Provera Claim
If you were diagnosed with meningioma after Depo-Provera exposure, this is the standard filing workflow most claimants follow.
Step 1: Gather Key Records
- Depo-Provera or generic medroxyprogesterone injection history
- MRI and diagnosis reports confirming meningioma
- Surgical, radiation, and follow-up treatment records
- Insurance and billing records showing medical expenses
Step 2: Confirm Your State Deadline
Check your state rules and then get legal confirmation. Latent injury timing, discovery-rule analysis, and repose statutes can change the deadline calculation.
Review your state deadline page.
Step 3: Complete Intake and Attorney Review
Provide your timeline and records for screening. Counsel evaluates exposure proof, diagnosis evidence, and filing viability before initiating formal action.
Step 4: Filing and Case Progress
Once filed, your case may proceed within coordinated MDL processes for pretrial handling. Most claimants do not attend court hearings early in the process.
Step 5: Stay Organized
Keep records current, track symptoms and treatment updates, and respond quickly to legal requests to avoid delays.
Ready to Start Filing Steps?
Begin with a confidential intake to confirm whether your claim is still within deadline.
Start Secure Intake →Related Resources
- Do I Qualify? — Quick eligibility check
- Settlement Factors — What determines claim value
- State Filing Deadlines — Statute of limitations by state
- Generic Medroxyprogesterone Claims — If you used the generic version
- MDL 3140 Updates — Current litigation status
Research & Sources
- Peyre M, et al. (2024). "Medroxyprogesterone acetate use and risk of intracranial meningioma." BMJ, 384: e078078. doi:10.1136/bmj-2023-078078. Key finding: 5.6x increased meningioma risk after ≥1 year use.
- U.S. FDA. (August 2024). FDA Safety Communication: Boxed warning for meningioma risk with Depo-Provera. fda.gov.
- FDA FAERS Database. (2024). 1,990 adverse event reports filed for medroxyprogesterone acetate — meningioma. FDA FAERS Public Dashboard.
- PACER Court Records. (April 2026). MDL 3140 — In re: Depo-Provera (Medroxyprogesterone Acetate) Products Liability Litigation, N.D. Fla. 3,099+ pending cases.